PROMUS™ Everolimus-Eluting Stent Added to Boston Scientific Coron
9
Favorable risk/benefit ratio seen for antiplatelet-anticoagulant
7
Drug-Eluting Stents Perform Best in Small Coronary Lesions最近发布在15
12
Cobalt-chromium everolimus-eluting stent better than Taxus for re
17
Two-Year Data Suggest Different Rates Of Blood Clots And Heart At
12
在刚刚结束的北京国际心血管病论坛（IHF）2006上，美国心血管研究基金会（CRF）的创始人，美国介入心脏学大会（TCT）的主席，
3
Thrombosis is the price for the success of drug-eluting stents还没有
10
Aspirin May Not Adequately Suppress Platelet Activity in CHD一项来自意
8
Top US cardiologist seeks sweeping stent study一个著名的美国心脏病专家呼吁开展大型长
9
Rosuvastatin plus ezetimibe gets 80% of high-risk patients to LDL
13
西班牙，巴塞罗那 ―― 当Drs Edoardo Camenzind (University Hospital Geneva, S
9
Biomarkers Predict Survival Benefit With Coronary Revascularizati
3
Pexelizumab Cuts Mortality in Patients With Acute MI or CABG一份系统回
2
OASIS-5 and-6 combined give more data on fondaparinuxOASIS-5和6 联合
8
Patients With AMI Have Multiple Unstable Carotid Plaques一份来自意大利学者
9
AHA/ACC: Docs overlooking flu shots miss opportunity to save live
8
Will bleeding be an issue with prasugrel?在2006年世界心血管病大会上，新发表的数据提起
4
BOSTON SCIENTIFIC Announces Excellent Results for Patients With B
3
HRS releases final ICD/pacemaker performance and surveillance gui
7
Many Major Cardiac Therapy Trials Exclude Patients With Renal Dis
2
作者：
作者：
作者：
作者：
作者：
作者：
作者：
作者：
闽公网安备35010202000257号 闽ICP备18022519号-2